GSA CAPITAL PARTNERS LLP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$386,000
+21.0%
324,784
+16.2%
0.05%
+18.6%
Q1 2022$319,000
+3.9%
279,605
+211.1%
0.04%
+38.7%
Q3 2021$307,000
-52.8%
89,878
-58.7%
0.03%
-57.5%
Q2 2021$651,000
-15.6%
217,687
-23.4%
0.07%
+69.8%
Q3 2018$771,000
+39.2%
284,354
-1.9%
0.04%
+59.3%
Q2 2018$554,000
-12.8%
289,854
-4.1%
0.03%
-20.6%
Q1 2018$635,000
+2167.9%
302,154
+2112.9%
0.03%
+1600.0%
Q4 2017$28,000
-89.7%
13,654
-29.8%
0.00%
-81.8%
Q1 2015$272,00019,4460.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders